• About us
• Contact

Advertisement

Document › Details

Danaher Corporation. (2/20/18). "Press Release: Danaher Announces Quarterly Dividend". Washington, DC.

	Organisation	Danaher Corporation (NYSE: DHR)
	Group	Danaher (Group)
	Product	laboratory equipment and instruments
	Product 2	analytical instrument
	Person	Gugino, Matthew E. (Danaher 201407 VP Investor Relations)

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share payable on April 27, 2018 to holders of record on March 29, 2018.


ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in some of the most demanding and attractive industries, including health care, environmental and industrial. With more than 20 operating companies, Danaher's globally diverse team of approximately 67,000 associates is united by a common culture and operating system, the Danaher Business System. For more information, please visit www.danaher.com.


For further information: Matthew E. Gugino, Vice President, Investor Relations, Danaher Corporation, 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, D.C. 20037, Telephone: (202) 828-0850, Fax: (202) 828-0860

Record changed: 2023-06-05

Advertisement

More documents for Danaher (Group)

• [1] Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.....
• [2] Danaher Corporation. (8/28/23). "Press Release: Danaher to Acquire Abcam". Washington, DC....
• [3] Molecular Devices, LLC. (2/7/23). "Press Release: Molecular Devices Partners with Seed Biosciences to Exclusively Offer DispenCell Single-Cell Dispenser, Expanding Leadership in Cell Line Development". San José, CA....
• [4] Molecular Devices, LLC. (1/4/23). "Press Release: Molecular Devices and Advanced Solutions Life Sciences Collaborate to Develop 3D Biology Automation Technologies for Drug Discovery". San José, CA....
• [5] Molecular Devices, LLC. (12/6/22). "Press Release: Molecular Devices Adds Proprietary Patient-derived Organoid Technology with Acquisition of Cellesce". San José, CA & Cardiff....
• [6] Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition"....
• [7] Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin....
• [8] HeartBeat.bio AG. (9/12/22). "Press Release: HeartBeat.bio and Molecular Devices Announce Collaboration to Automate and Scale Cardiac Organoids for High-throughput Screening in Drug Discovery". Vienna & San José, CA....
• [9] AB Sciex (d/b/a Sciex). (11/1/21). "Press Release: Sciex and Evosep Will Collaborate to Provide Robust, High-throughput Proteomics Workflows"....
• [10] Scitara Corporation. (6/30/21). "Press Release: Scitara Corporation Unleashes Universal Connectivity to Redefine Lab of the Future". Marlborough, MA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.